Hypertrophic chondrocytes serve as a reservoir for marrow associated skeletal stem and progenitor cells, osteoblasts, and adipocytes during skeletal development

Abstract

Hypertrophic chondrocytes give rise to osteoblasts during skeletal development; however, the process by which these non-mitotic cells make this transition is not well understood. Prior studies have also suggested that skeletal stem and progenitor cells (SSPCs) localize to the surrounding periosteum and serve as a major source of marrow associated SSPCs, osteoblasts, osteocytes, and adipocytes during skeletal development. To further understand the cell transition process by which hypertrophic chondrocytes contribute to osteoblasts or other marrow associated cells, we utilized inducible and constitutive hypertrophic chondrocyte lineage tracing and reporter mouse models (Col10a1CreERT2; Rosa26fs-tdTomato and Col10a1Cre; Rosa26fs-tdTomato) in combination with a PDGFRaH2B-GFP transgenic line, single cell RNA-sequencing, bulk RNA-sequencing, immunofluorescence staining, and cell transplantation assays. Our data demonstrate that hypertrophic chondrocytes undergo a process of dedifferentiation to generate marrow associated SSPCs that serve as a primary source of osteoblasts during skeletal development. These hypertrophic chondrocyte derived SSPCs commit to a CXCL12-abundant reticular (CAR) cell phenotype during skeletal development and demonstrate unique abilities to recruit vasculature and promote bone marrow establishment, while also contributing to the adipogenic lineage.

Data availability

All raw data has been made available as source data files within the manuscript. All sequencing datasets are available via the Gene Expression Omnibus (GEO) under the accession numbers: GSE179174, GSE190616, and GSE179148.

The following data sets were generated

Article and author information

Author details

  1. Jason T Long

    Department of Cell Biology, Duke University School of Medicine, Durham, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6006-0932
  2. Abigail Leinroth

    Department of Cell Biology, Duke University School of Medicine, Durham, United States
    Competing interests
    No competing interests declared.
  3. Yihan Liao

    Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, United States
    Competing interests
    No competing interests declared.
  4. Yinshi Ren

    Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, United States
    Competing interests
    No competing interests declared.
  5. Anthony J Mirando

    Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, United States
    Competing interests
    No competing interests declared.
  6. Tuyet Nguyen

    Program of Developmental and Stem Cell Biology, Duke University School of Medicine, Durham, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8769-9955
  7. Wendi Guo

    Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, United States
    Competing interests
    No competing interests declared.
  8. Deepika Sharma

    Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, United States
    Competing interests
    No competing interests declared.
  9. Douglas Rouse

    Division of Laboratory Animal Resources, Duke University School of Medicine, Durham, United States
    Competing interests
    No competing interests declared.
  10. Colleen Wu

    Department of Cell Biology, Duke University School of Medicine, Durham, United States
    Competing interests
    No competing interests declared.
  11. Kathryn Song Eng Cheah

    School of Biomedical Sciences, University of Hong Kong, Hong Kong, Hong Kong
    Competing interests
    Kathryn Song Eng Cheah, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0802-8799
  12. Courtney M Karner

    Department of Cell Biology, Duke University School of Medicine, Durham, United States
    Competing interests
    No competing interests declared.
  13. Matthew J Hilton

    Department of Cell Biology, Duke University School of Medicine, Durham, United States
    For correspondence
    matthew.hilton@duke.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3165-267X

Funding

NIH/NIAMS (R01AR071722)

  • Matthew J Hilton

NIH/NIAMS (R01AR063071)

  • Matthew J Hilton

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to and approved by the Duke University Institutional Animal Care and Use Committees (IACUC) (A068-20-03).

Copyright

© 2022, Long et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,523
    views
  • 636
    downloads
  • 42
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jason T Long
  2. Abigail Leinroth
  3. Yihan Liao
  4. Yinshi Ren
  5. Anthony J Mirando
  6. Tuyet Nguyen
  7. Wendi Guo
  8. Deepika Sharma
  9. Douglas Rouse
  10. Colleen Wu
  11. Kathryn Song Eng Cheah
  12. Courtney M Karner
  13. Matthew J Hilton
(2022)
Hypertrophic chondrocytes serve as a reservoir for marrow associated skeletal stem and progenitor cells, osteoblasts, and adipocytes during skeletal development
eLife 11:e76932.
https://doi.org/10.7554/eLife.76932

Share this article

https://doi.org/10.7554/eLife.76932

Further reading

    1. Developmental Biology
    2. Stem Cells and Regenerative Medicine
    Thi Thom Mac, Teddy Fauquier ... Thierry Brue
    Research Article

    Deficient Anterior pituitary with common Variable Immune Deficiency (DAVID) syndrome results from NFKB2 heterozygous mutations, causing adrenocorticotropic hormone deficiency (ACTHD) and primary hypogammaglobulinemia. While NFKB signaling plays a crucial role in the immune system, its connection to endocrine symptoms is unclear. We established a human disease model to investigate the role of NFKB2 in pituitary development by creating pituitary organoids from CRISPR/Cas9-edited human induced pluripotent stem cells (hiPSCs). Introducing homozygous TBX19K146R/K146R missense pathogenic variant in hiPSC, an allele found in congenital isolated ACTHD, led to a strong reduction of corticotrophs number in pituitary organoids. Then, we characterized the development of organoids harboring NFKB2D865G/D865G mutations found in DAVID patients. NFKB2D865G/D865G mutation acted at different levels of development with mutant organoids displaying changes in the expression of genes involved on pituitary progenitor generation (HESX1, PITX1, LHX3), hypothalamic secreted factors (BMP4, FGF8, FGF10), epithelial-to-mesenchymal transition, lineage precursors development (TBX19, POU1F1) and corticotrophs terminal differentiation (PCSK1, POMC), and showed drastic reduction in the number of corticotrophs. Our results provide strong evidence for the direct role of NFKB2 mutations in the endocrine phenotype observed in patients leading to a new classification of a NFKB2 variant of previously unknown clinical significance as pathogenic in pituitary development.

    1. Developmental Biology
    2. Genetics and Genomics
    Debashish U Menon, Prabuddha Chakraborty ... Terry Magnuson
    Research Article

    We present evidence implicating the BAF (BRG1/BRM Associated Factor) chromatin remodeler in meiotic sex chromosome inactivation (MSCI). By immunofluorescence (IF), the putative BAF DNA binding subunit, ARID1A (AT-rich Interaction Domain 1 a), appeared enriched on the male sex chromosomes during diplonema of meiosis I. Germ cells showing a Cre-induced loss of ARID1A arrested in pachynema and failed to repress sex-linked genes, indicating a defective MSCI. Mutant sex chromosomes displayed an abnormal presence of elongating RNA polymerase II coupled with an overall increase in chromatin accessibility detectable by ATAC-seq. We identified a role for ARID1A in promoting the preferential enrichment of the histone variant, H3.3, on the sex chromosomes, a known hallmark of MSCI. Without ARID1A, the sex chromosomes appeared depleted of H3.3 at levels resembling autosomes. Higher resolution analyses by CUT&RUN revealed shifts in sex-linked H3.3 associations from discrete intergenic sites and broader gene-body domains to promoters in response to the loss of ARID1A. Several sex-linked sites displayed ectopic H3.3 occupancy that did not co-localize with DMC1 (DNA meiotic recombinase 1). This observation suggests a requirement for ARID1A in DMC1 localization to the asynapsed sex chromatids. We conclude that ARID1A-directed H3.3 localization influences meiotic sex chromosome gene regulation and DNA repair.